Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells.

Klaihmon, Phatchanat; Luanpitpong, Sudjit; Kang, Xing; Issaragrisil, Surapol

Klaihmon, Phatchanat; Luanpitpong, Sudjit; Kang, Xing; Issaragrisil, Surapol.

Afiliação

Klaihmon P; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Luanpitpong S; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kang X; Blood Products and Cellular Immunotherapy Research Group, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Issaragrisil S; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Cancer Cell Int ; 23(1): 297, 2023 Nov 27.

Article em En | MEDLINE | ID: mdl-38012684